This article appeared on December 14, 2020 in Brandon J. Weichert’s op-ed column at The Washington Times. The outbreak of … More
I’m sitting here in quarantine, watching the economy die; listening to my neighbors tell me horror stories of how their … More
Geopolitical analyst and tech expert, Brandon J. Weichert, explores the potential origins of the coronavirus with Gordon G. Chang and … More
Society is governed by institutions that have increasingly been under siege both from bad actors within their organizations and from … More
Geopolitical analyst and writer of Republic Book Publisher’s soon-to-be-released (this Fall) book, “Winning Space: How America Remains a Superpower,” talks … More
It is only through competition with China in the biotech market that Washington will ensure advanced capabilities are not so readily handed over to Chinese biotech firms (and, therefore, the Chinese military). In this way we may slow China’s development into a biotechnology superpower and give ourselves the time we need to better compete with China in this vital area.
“Bio-hacking, gene-doping, and genetic manipulation are not only the next frontiers for bettering human life. They are, more troublingly, the battlefields of the future. The West is unprepared. What’s worse is that many Western firms are helping to empower America’s enemies in China.”
“The president’s options on North Korea are bad. However, the president must make a choice. This is the sad world we currently live in today. It’s a simple lose-lose calculation: do we lose little by dictating the course of conflict with preemptive strikes before North Korea gets fully functional ICBMs, or do we lose big by suffering a mass casualty attack and, potentially, being forced out of the Asia-Pacific entirely?”